Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Nicorette Inhaler

This article was originally published in The Tan Sheet

Executive Summary

Nicorette Inhaler: Smoking cessation inhaler-based drug delivery system is launched as an over-the-counter pharmaceutical product in Denmark, Pharmacia & Upjohn announces Sept. 6. The product also is approved in Italy and the Netherlands, where it will bow before the end of the year. Pharmacia & Upjohn filed an NDA in the U.S. in May; McNeil will market the product in North America under a 1995 agreement with Pharmacia. Pharmacia & Upjohn has conducted six clinical trials on the inhaler involving 1,440 smokers in countries including Denmark, Great Britain and the U.S. The product is based on technology developed by Advanced Therapeutic Products that was acquired by Pharmacia & Upjohn in 1987...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel